Skip to main content
. 2017 Mar 31;17:236. doi: 10.1186/s12885-017-3233-5

Table 1.

Clinical data and ALK results

No MCCa MCV age Tumor location Tumor size mm ALK NGSb ALK IHC D5F3 5A4 ALK FISHc
1 P2 pos < 80 Right cheek + + −
2 P3 pos ≥ 80 Posterior thigh 85 + + − +
3 P4 pos < 80 Thorax 70 + + −
4 P5 pos < 80 Right knee 12 + + −
5 P9 pos ≥ 80 unknown 20 + + +
6 N10 neg ≥ 80 Right arm 50 + + + +
7 N11 neg ≥ 80 Left temple 15 – –
8 P12 pos ≥ 80 Forehead 40 + + −
9 P13 pos < 80 Right buttock 34 + + −
10 P14 pos ≥ 80 Left cheek 18 + + −
11 N17 neg < 80 Right cheek 20 + + −
12 N18 neg < 80 Right breast 20 + + −
13 N19 neg < 80 Calf 13 + + −
14 N21 neg < 80 Neck 25 + + −
15 P23 pos < 80 Left forearm 40 + + −
16 N25 neg ≥ 80 Left back + + − +
17 P26 pos ≥ 80 Right shoulder 24 + + −
18 P28 pos ≥ 80 Left arm 75 +
19 N29 neg ≥ 80 Back 75 – –
20 N31 neg < 80 Left foot 10 + + +
21 N32 neg ≥ 80 Right breast 23 (+)
22 N33 neg ≥ 80 Front of left ear 18 (+)
23 P34 pos < 80 Flank 20 + + + +
24 N35 neg < 80 Upper abdomen 25 + + −
25 P36 pos < 80 Right buttock 30 +
26 N37 neg ≥ 80 Right cheek 30 + + − +

aMCC tumor number. bCases that had high expression of ALK by NGS are marked +. cTumors with 3 or more dual signals in FISH are marked +. In cases N32 and N33, low proportion of tumor cells stained positive with D5F3 and thus are marked (+)